AI imaging solutions for the early, efficient detection of lung disease.
FDA Cleared | CE Marked | Clinically Proven | Enterprise Wide
The ClearRead™ suite aims to aid the more arduous medical interpretation tasks, including a systematic, thorough investigation of each voxel so that radiologists can focus on actual clinical decision making and improving their patients’ lives.
ClearRead significantly improves a clinician’s ability to accurately and efficiently detect disease – suppressing vessels in thoracic CT and bone structures in chest X-ray images – for earlier, more efficient detection of lung abnormalities. Powered by the most advanced machine learning and modeling methods available to the medical imaging market, the patented, FDA-cleared, CE marked software tools are deployable in the clinic or the Cloud.
ClearRead CT is the first FDA-cleared device to support concurrent reading, allowing for faster reading with proven, superior, automatic nodule detection performance for all nodule types, including solid, sub-solid and ground-glass nodules.
ClearRead Xray platform is comprised of four FDA-cleared applications designed to improve reading efficiency and accuracy across the hospital enterprise without requiring additional hardware. The solutions optimize the diagnostic value of all portable and upright images.
Machine learning technology
Machine (deep) learning: for optimized content, workflow, and results. Model-driven AI: deep neural networks augmented with accurate disease simulation.
Image processing technology
Optimized image content and image harmonization. Adaptive image normalization: robust, turn-key, future proof, enterprise-ready solutions in the Cloud or in the clinic.
Increase your institutional effectiveness
Provides enterprise capable solutions that support unification of care across the entire enterprise.
Provides “Future Proof” solutions that seamlessly adapt to changes in hospital environments.
Provides cost effective solutions for institutions of all sizes.